Andrew J. Bishop

Andrew J. Bishop is an Associate Professor of Radiation Oncology at The University of Texas MD Anderson Cancer Center. His research focuses on clinical radiation oncology, specifically the multimodality management of soft tissue sarcoma, chordoma, and cutaneous malignancies, including melanoma. He investigates the role of proton beam therapy, neoadjuvant immunotherapy combinations, and primary-site radiotherapy in metastatic and high-risk disease. His recent work includes phase II trials of cetuximab in chordoma and atezolizumab with radiation for resectable sarcomas, alongside studies on sinonasal mucosal melanoma and global access to proton therapy.